COVID Supplement to Terry Beirn CPCRA Clinical Trials Unit
COVID Supplement to Terry Beirn CPCRA Clinical Trials Unit
Terry Beirn CPRA 临床试验部门的新冠肺炎补充
批准号：
10166265
负责人：
Virginia Kan
金额：
$60.19万
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
项目状态：
已结题
起止时间：
2020-06-04 至 2020-11-30
关键词：
2019-nCoVAcquired Immunodeficiency SyndromeAdministrative SupplementCOVID-19CitiesClinical ResearchClinical Research AssociateClinical TrialsClinical Trials UnitCollaborationsCommunitiesFundingGeneral PopulationGoalsInfectionPrincipal InvestigatorRampResearchSiteTestingTexasUniversitiesVirginiaWashingtonclinical research sitecoronavirus diseasepandemic diseaseprogramsresponse
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CPCRA CTU # 60407: Admin Supplement NOT-AI-20-031 & PA-18-591 Principal Investigator: KAN, Virginia L.
PROJECT SUMMARY/ABSTRACT
The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) Clinical Trials Unit (CTU)
# 60407 is pleased to submit an Administrative Supplement application in response to NOT-AI-20-031 and PA-
18-591 through the George Washington University (GWU), the applicant organization, in collaboration with two
affiliated Clinical Research Sites (CRSs). This CTU is led by Virginia L. Kan, MD, Principal Investigator.
This supplement will provide funding to expand SARS-CoV-2 testing at the following two CTU-affiliated Clinical
Research Sites:
Site 01: George Washington University (GWU) CRS # 31608, Washington, DC
Site 02: Houston AIDS Research Team (HART) CRS # 31473, Houston, TX
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Pharmacologic Treatment of Psychiatric Disorders and Time With Unsuppressed HIV Viral Load in a Clinical HIV Cohort.
临床 HIV 队列中精神疾病的药物治疗和 HIV 病毒载量不受抑制的时间。
临床 HIV 队列中精神疾病的药物治疗和 HIV 病毒载量不受抑制的时间。
DOI：
10.1097/qai.0000000000002138
发表时间：
2019
期刊：
Journal of acquired immune deficiency syndromes (1999)
影响因子：
--
作者：
[Levy,MatthewE, Monroe,AnneK, Horberg,MichaelA, Benator,DebraA, Molock,Sherry, Doshi,RupaliK, PowersHapp,Lindsey, Castel,AmandaD]
通讯作者：
Castel,AmandaD
Cholesterol-lowering effect of statin therapy in a clinical HIV cohort: an application of double propensity score adjustment.
他汀类药物治疗在临床 HIV 队列中的降胆固醇作用：双重倾向评分调整的应用。
他汀类药物治疗在临床 HIV 队列中的降胆固醇作用：双重倾向评分调整的应用。
DOI：
10.1016/j.annepidem.2020.02.005
发表时间：
2020
期刊：
Annals of epidemiology
影响因子：
5.6
作者：
[Levy,MatthewE, Ma,Yan, Magnus,Manya, Younes,Naji, Castel,AmandaD, DCCohortExecutiveCommittee]
通讯作者：
DCCohortExecutiveCommittee
海外基金
